Maxcyte (MXCT) Change in Inventory (2020 - 2026)

Maxcyte has reported Change in Inventory over the past 6 years, most recently at $72000.0 for Q4 2025.

  • Quarterly Change in Inventory rose 113.66% to $72000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$575000.0 through Dec 2025, up 57.78% year-over-year, with the annual reading at -$575000.0 for FY2025, 57.78% up from the prior year.
  • Change in Inventory was $72000.0 for Q4 2025 at Maxcyte, down from $107000.0 in the prior quarter.
  • Over five years, Change in Inventory peaked at $1.7 million in Q1 2023 and troughed at -$664000.0 in Q2 2024.
  • The 5-year median for Change in Inventory is $179550.0 (2021), against an average of $374790.0.
  • Year-over-year, Change in Inventory plummeted 218.16% in 2024 and then soared 5450.0% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $1.1 million in 2021, then tumbled by 44.62% to $612300.0 in 2022, then fell by 27.16% to $446000.0 in 2023, then plummeted by 218.16% to -$527000.0 in 2024, then soared by 113.66% to $72000.0 in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Change in Inventory are $72000.0 (Q4 2025), $107000.0 (Q3 2025), and -$223000.0 (Q2 2025).